Success Metrics

Clinical Success Rate
100.0%

Based on 7 completed trials

Completion Rate
100%(7/7)
Active Trials
3(25%)
Results Posted
14%(1 trials)

Phase Distribution

Ph not_applicable
5
42%
Ph phase_3
1
8%
Ph early_phase_1
1
8%
Ph phase_2
2
17%

Phase Distribution

1

Early Stage

2

Mid Stage

1

Late Stage

Phase Distribution9 total trials
Early Phase 1First-in-human
1(11.1%)
Phase 2Efficacy & side effects
2(22.2%)
Phase 3Large-scale testing
1(11.1%)
N/ANon-phased studies
5(55.6%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

87.5%

7 of 8 finished

Non-Completion Rate

12.5%

1 ended early

Currently Active

3

trials recruiting

Total Trials

12

all time

Status Distribution
Active(3)
Completed(7)
Terminated(1)
Other(1)

Detailed Status

Completed7
Recruiting3
Withdrawn1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
12
Active
3
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Early Phase 11 (11.1%)
Phase 22 (22.2%)
Phase 31 (11.1%)
N/A5 (55.6%)

Trials by Status

recruiting325%
completed758%
withdrawn18%
unknown18%

Recent Activity

3 active trials
Showing 5 of 12
recruitingphase_2

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

NCT06031688
recruitingnot_applicable

Refining Local-Regional Therapy for IBC

NCT04636710
recruiting

Early Diagnosis of Breast Cancer-related Lymphedema

NCT06046365
completednot_applicable

Comparison of Use of Indocyanine Green and 99mTc-labeled Radiotracer for Axillary Lymphatic Mapping in Patients With Breast Cancer

NCT02419807
completed

Laparoscopic Sentinel Lymph Node Localization in Operable Cervix Cancer

NCT00205010
View all 12 trials

Clinical Trials (12)

Showing 12 of 12 trials
NCT06031688Phase 2

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

Recruiting
NCT04636710Not Applicable

Refining Local-Regional Therapy for IBC

Recruiting
NCT06046365

Early Diagnosis of Breast Cancer-related Lymphedema

Recruiting
NCT02419807Not Applicable

Comparison of Use of Indocyanine Green and 99mTc-labeled Radiotracer for Axillary Lymphatic Mapping in Patients With Breast Cancer

Completed
NCT00205010

Laparoscopic Sentinel Lymph Node Localization in Operable Cervix Cancer

Completed
NCT00743314Early Phase 1

Single-Photon Emission Computed Tomography, Computed Tomography Lymphoscintigraphy, and Intensity-Modulated Radiation Therapy in Treating Patients Who Have Undergone Surgery for Stage I or Stage II Breast Cancer

Completed
NCT01642511Phase 2

Internal Mammary Sentinel Lymph Node Biopsy in Early Breast Cancer Patients With Clinically Axillary Node -Negative

Completed
NCT03468374Not Applicable

Sentinel Lymph Node Identification in Patients With Breast Cancer Using SPECT/CT

Unknown
NCT02140385Not Applicable

Role of Preservation of Scarpa's Fascia in Abdominoplasty

Withdrawn
NCT00014612Phase 3

Comparison of Complete Axillary Lymph Node Dissection With Axillary Radiation Therapy in Treating Women With Invasive Breast Cancer

Completed
NCT00528034Not Applicable

Lymphoscintigraphy in Patients With Vaginal Cancer

Completed
NCT01164748

Lymphatic Mapping After Previous Breast Surgery

Completed

All 12 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
12